Chemoinformaics analysis of Benzyl 2,6-dimethoxybenzoate
| Molecular Weight | 272.3 | nRot | 5 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 13 |
| Exact Molecular Weight | 272.105 | nRing | 2 |
| Solubility: LogS | -3.508 | nHRing | 0 |
| Solubility: LogP | 2.823 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 40.5967 |
| nHD | 0 | BPOL | 22.1273 |
| QED | 0.785 |
| Synth | 1.583 |
| Natural Product Likeliness | -0.264 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.656 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.687 |
| MDCK | 0.0000292 |
| BBB | 0.467 |
| PPB | 0.924876 |
| VDSS | 0.787 |
| FU | 0.0362946 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.933 |
| CYP2c19-inh | 0.973 |
| CYP2c19-sub | 0.434 |
| CYP2c9-inh | 0.835 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.582 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.704 |
| CYP3a4-sub | 0.588 |
| CL | 10.61 |
| T12 | 0.685 |
| hERG | 0.217 |
| Ames | 0.096 |
| ROA | 0.01 |
| SkinSen | 0.413 |
| Carcinogencity | 0.583 |
| EI | 0.958 |
| Respiratory | 0.061 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.678223 |